Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/09/21 → 31/08/22 |
Funding
- King’s College London: £21,142.00
Proof of Principle for DNM1 epileptic encephalopathy treatment using CRISPR-based gene/RNA therapies
- Cousin, Michael (Principal Investigator)
- Gonzalez Sulser, Alfredo (Co-investigator)